Clinical Trial Update: Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 safety and pharmacokinetics study of fostemsavir in combination with optimized background therapy for HIV-1 infected children and adolescents with m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Fostemsavir (fostemsavir)

Snippet

Sponsor: PENTA Foundation | Conditions: HIV Infections With Multi Drug Resistant Virus | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING